Gaddy Getz, Ph.D.
Harvard Medical School Member, Broad Institute Of MIT And Harvard
Dr. Gaddy Getz is an internationally acclaimed leader in cancer genomics and a pioneer of widely used tools for analyzing cancer genomes. Dr. Getz is an institute member of the…
Dr. Gaddy Getz is an internationally acclaimed leader in cancer genomics and a pioneer of widely used tools for analyzing cancer genomes. Dr. Getz is an institute member of the Broad Institute of MIT and Harvard, where he directs the Cancer Genome Computational Analysis Group. Dr. Getz is a Professor of Pathology at Harvard Medical School and a faculty member and Director of Bioinformatics at the Massachusetts General Hospital (MGH) Cancer Center and Department of Pathology. He is also the inaugural incumbent of the Paul C. Zamecnik Chair in Oncology at the MGH Cancer Center.
In addition to his roles at the MGH and the Broad Institute, Dr. Getz is the principal investigator of the Processing Genome Data Analysis Center (GDAC), as part of the NCI Genome Data Analysis Network; a co-leader of the International Cancer Genome Consortium (ICGC) Pan-Cancer Analysis of Whole Genomes (PCAWG) project; and a co-principal investigator of the Broad’s Proteogenomics Data Analysis Center. Getz was a member of the NCI’s Cancer Moonshot Blue Ribbon Panel and co-led one of three NCI Cloud Pilots. He has published numerous papers in prominent journals describing new methodologies to study cancer genomes that have identified new genes and pathways involved in different tumor types, mutational signatures and tumor evolution.
Dr. Getz received his B.S. degree in physics and mathematics from The Hebrew University of Jerusalem and an M.Sc. in physics from Tel Aviv University. He later earned a Ph.D. in physics from the Weizmann Institute of Science in Israel. He completed his postdoctoral training at the Broad Institute of MIT and Harvard with Todd Golub, where he focused on developing computational tools and analyzing expression of miRNAs across cancer.